SCRI - Tennessee Oncology — Nashville, Tennessee

SCRI - Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI - Tennessee Oncology has participated in 13 clinical trials with 3 currently active.

Therapeutic areas: Solid Tumors, Carcinoma, Pancreatic Ductal, Glioblastoma Multiforme.

Sponsors: EMD Serono Research & Development Institute, Inc., Sumitomo Pharma America, Inc., NovoCure Ltd..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Tennessee Oncology?

SCRI - Tennessee Oncology has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Tennessee Oncology conducted?

SCRI - Tennessee Oncology has 13 clinical trials on record, with 3 currently active. Their work covers Solid Tumors, Carcinoma, Pancreatic Ductal, Glioblastoma Multiforme.

Is SCRI - Tennessee Oncology accredited by Crixeo Health?

Yes — SCRI - Tennessee Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about SCRI - Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.